How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018
- Author
- Ine Wouters, Stefanie Desmet, Liesbet Van Heirstraeten, Sereina A Herzog, Philippe Beutels, Jan Verhaegen, Herman Goossens, Pierre Van Damme, Surbhi Malhotra-Kumar, Heidi Theeten, [missing] NPcarriage Study Group, David Tuerlinckx, Adam Finn, Koen Van Herck (UGent) , Robert Cohen and Christine Lammens
- Organization
- Abstract
- Background: The current carriage study was set up to reinforce surveillance during/after the PCV13-to-PCVC10 switch in Belgium. Aim: This observational study monitored carriage of Streptococcus pneumoniae (Sp) serotypes, particularly those no longer covered (3, 6A, 19A), as well as Haemophilus influenzae (Hi), because PCV10 contains the non-typeable Hi protein D. Methods: A total of 2,615 nasopharyngeal swabs from children (6-30 months old) attending day care were collected in three periods over 2016-2018. Children's demographic and clinical characteristics and vaccination status were obtained through a questionnaire. Sp and Hi were identified by culture and PCR. Pneumococcal strains were tested for antimicrobial (non-)susceptibility by disc diffusion and serotyped by Quellung-reaction (Quellung-reaction and PCR for serotypes 3, 6A, 19A). Results: The carriage prevalence of Sp (> 75%) remained stable over the successive periods but that of Hi increased (87.4%, 664 Hi-carriers/760 in 2016 vs 93.9%, 895/953 in 2017-2018). The proportion of non-PCV13 vaccine serotypes decreased (94.6%, 438 isolates/463 in 2016 vs 89.7%, 599/668 in 2017-2018) while that of PCV13-non-PCV10 vaccine serotypes (3 + 6A + 19A) increased (0.9%, 4 isolates/463 in 2016 vs 7.8%, 52/668 in 2017-2018), with serotype 19A most frequently identified (87.9%, 58/66 isolates). Non-susceptibility of pneumococci against any of the tested antibiotics was stable over the study period (> 44%). Conclusions: During and after the PCV13-to-PCV10 vaccine switch, the proportion of non-PCV13 serotypes decreased, mainly due to a serotype 19A carriage prevalence increase. These results complement invasive pneumococcal disease surveillance data, providing further basis for pneumococcal vaccination programme policy making.
- Keywords
- ATTENDING DAY-CARE, STREPTOCOCCUS-PNEUMONIAE, CONJUGATE VACCINE, HAEMOPHILUS-INFLUENZAE, STAPHYLOCOCCUS-AUREUS, CHILDREN YOUNGER, OTITIS-MEDIA, BACTERIAL, COLONIZATION, IMPACT
Downloads
-
eurosurv-25-5-6.pdf
- full text (Published version)
- |
- open access
- |
- |
- 386.31 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8665297
- MLA
- Wouters, Ine, et al. “How Nasopharyngeal Pneumococcal Carriage Evolved during and after a PCV13-to-PCV10 Vaccination Programme Switch in Belgium, 2016 to 2018.” EUROSURVEILLANCE, vol. 25, no. 5, 2020, pp. 32–44, doi:10.2807/1560-7917.es.2020.25.5.1900303.
- APA
- Wouters, I., Desmet, S., Van Heirstraeten, L., Herzog, S. A., Beutels, P., Verhaegen, J., … Lammens, C. (2020). How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018. EUROSURVEILLANCE, 25(5), 32–44. https://doi.org/10.2807/1560-7917.es.2020.25.5.1900303
- Chicago author-date
- Wouters, Ine, Stefanie Desmet, Liesbet Van Heirstraeten, Sereina A Herzog, Philippe Beutels, Jan Verhaegen, Herman Goossens, et al. 2020. “How Nasopharyngeal Pneumococcal Carriage Evolved during and after a PCV13-to-PCV10 Vaccination Programme Switch in Belgium, 2016 to 2018.” EUROSURVEILLANCE 25 (5): 32–44. https://doi.org/10.2807/1560-7917.es.2020.25.5.1900303.
- Chicago author-date (all authors)
- Wouters, Ine, Stefanie Desmet, Liesbet Van Heirstraeten, Sereina A Herzog, Philippe Beutels, Jan Verhaegen, Herman Goossens, Pierre Van Damme, Surbhi Malhotra-Kumar, Heidi Theeten, [missing] NPcarriage Study Group, David Tuerlinckx, Adam Finn, Koen Van Herck, Robert Cohen, and Christine Lammens. 2020. “How Nasopharyngeal Pneumococcal Carriage Evolved during and after a PCV13-to-PCV10 Vaccination Programme Switch in Belgium, 2016 to 2018.” EUROSURVEILLANCE 25 (5): 32–44. doi:10.2807/1560-7917.es.2020.25.5.1900303.
- Vancouver
- 1.Wouters I, Desmet S, Van Heirstraeten L, Herzog SA, Beutels P, Verhaegen J, et al. How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018. EUROSURVEILLANCE. 2020;25(5):32–44.
- IEEE
- [1]I. Wouters et al., “How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018,” EUROSURVEILLANCE, vol. 25, no. 5, pp. 32–44, 2020.
@article{8665297, abstract = {{Background: The current carriage study was set up to reinforce surveillance during/after the PCV13-to-PCVC10 switch in Belgium. Aim: This observational study monitored carriage of Streptococcus pneumoniae (Sp) serotypes, particularly those no longer covered (3, 6A, 19A), as well as Haemophilus influenzae (Hi), because PCV10 contains the non-typeable Hi protein D. Methods: A total of 2,615 nasopharyngeal swabs from children (6-30 months old) attending day care were collected in three periods over 2016-2018. Children's demographic and clinical characteristics and vaccination status were obtained through a questionnaire. Sp and Hi were identified by culture and PCR. Pneumococcal strains were tested for antimicrobial (non-)susceptibility by disc diffusion and serotyped by Quellung-reaction (Quellung-reaction and PCR for serotypes 3, 6A, 19A). Results: The carriage prevalence of Sp (> 75%) remained stable over the successive periods but that of Hi increased (87.4%, 664 Hi-carriers/760 in 2016 vs 93.9%, 895/953 in 2017-2018). The proportion of non-PCV13 vaccine serotypes decreased (94.6%, 438 isolates/463 in 2016 vs 89.7%, 599/668 in 2017-2018) while that of PCV13-non-PCV10 vaccine serotypes (3 + 6A + 19A) increased (0.9%, 4 isolates/463 in 2016 vs 7.8%, 52/668 in 2017-2018), with serotype 19A most frequently identified (87.9%, 58/66 isolates). Non-susceptibility of pneumococci against any of the tested antibiotics was stable over the study period (> 44%). Conclusions: During and after the PCV13-to-PCV10 vaccine switch, the proportion of non-PCV13 serotypes decreased, mainly due to a serotype 19A carriage prevalence increase. These results complement invasive pneumococcal disease surveillance data, providing further basis for pneumococcal vaccination programme policy making.}}, author = {{Wouters, Ine and Desmet, Stefanie and Van Heirstraeten, Liesbet and Herzog, Sereina A and Beutels, Philippe and Verhaegen, Jan and Goossens, Herman and Van Damme, Pierre and Malhotra-Kumar, Surbhi and Theeten, Heidi and NPcarriage Study Group, [missing] and Tuerlinckx, David and Finn, Adam and Van Herck, Koen and Cohen, Robert and Lammens, Christine}}, issn = {{1560-7917}}, journal = {{EUROSURVEILLANCE}}, keywords = {{ATTENDING DAY-CARE,STREPTOCOCCUS-PNEUMONIAE,CONJUGATE VACCINE,HAEMOPHILUS-INFLUENZAE,STAPHYLOCOCCUS-AUREUS,CHILDREN YOUNGER,OTITIS-MEDIA,BACTERIAL,COLONIZATION,IMPACT}}, language = {{eng}}, number = {{5}}, pages = {{32--44}}, title = {{How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018}}, url = {{http://doi.org/10.2807/1560-7917.es.2020.25.5.1900303}}, volume = {{25}}, year = {{2020}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: